| Identification | Back Directory | [Name]
2,6-Piperidinedione,4,4-dimethyl-1-[4-[4-(2- pyrimidinyl)-1-piperazinyl]butyl]-,monohydrochloride | [CAS]
83928-66-9 | [Synonyms]
RRSYY(Avadomide)-6
GepironeHydrochloride
2,6-Piperidinedione,4,4-dimethyl-1-[4-[4-(2- pyrimidinyl)-1-piperazinyl]butyl]-,monohydrochloride
2,6-Piperidinedione, 4,4-dimethyl-1-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, hydrochloride (1:1) | [Molecular Formula]
C19H30ClN5O2 | [MDL Number]
MFCD11840755 | [MOL File]
83928-66-9.mol | [Molecular Weight]
395.927 |
| Chemical Properties | Back Directory | [Melting point ]
192.5-195.5 °C | [solubility ]
H2O: 2 mg/mL, clear | [form ]
powder | [color ]
white to beige | [InChI]
InChI=1S/C19H29N5O2.ClH/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18;/h5-7H,3-4,8-15H2,1-2H3;1H | [InChIKey]
DGOCVISYYYQFEP-UHFFFAOYSA-N | [SMILES]
N1(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)CC(C)(C)CC1=O.[H]Cl |
| Hazard Information | Back Directory | [Uses]
Tranquilizer. | [Clinical Use]
Gepirone hydrochloride is primarily intended for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).
| [IC 50]
5-HT1A Receptor |
|
|